JOSEPH LUCAS: Open Payments
NPI 1538118500 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,164 in 58 payments from 11 companies in 2025. Trend: 2023 $1,248 · 2024 $432 · 2025 $1,164
Food & beverage: $1,164
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $230 |
| Axsome Therapeutics, Inc. | 9 | $222 |
| ABBVIE INC. | 17 | $190 |
| Otsuka America Pharmaceutical, Inc. | 6 | $157 |
| Teva Pharmaceuticals USA, Inc. | 5 | $103 |
| Neurocrine BioSciences, Inc. | 4 | $102 |
| Vanda Pharmaceuticals Inc. | 2 | $53 |
| Lundbeck LLC | 2 | $51 |
| Tris Pharma Inc | 1 | $20 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
Products named: CAPLYTA, Auvelity, VRAYLAR, REXULTI, INGREZZA, UZEDY, FANAPT, ABILIFY MAINTENA.
Industry payments across AL — which companies pay providers there.
